Xuan Ye Zhang

Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China

SCHOLARLY PAPERS

3

DOWNLOADS

67

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Perioperative Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone for Patients with Resectable Pulmonary Lymphoepithelioma-Like Carcinoma

Number of pages: 30 Posted: 01 Oct 2024
affiliation not provided to SSRN, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, affiliation not provided to SSRN, Sun Yat-sen University (SYSU) - Sun Yat-sen Memorial Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 24 (1,110,029)

Abstract:

Loading...

PD-1, PD-L1, pulmonary lymphoepithelioma-like carcinoma, Immunotherapy, Chemotherapy, Perioperative, surgery

2.

Impact of Prophylactic Dexamethasone on the Efficacy of Immune Checkpoint Inhibitors Plus Platinum-Based Chemotherapy in Patients with Advanced Non-Squamous Non-Small-Cell Lung Cancer

Number of pages: 23 Posted: 02 Mar 2023
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Huazhong University of Science and Technology - Department of Oncology, Zhejiang University - Department of Medical Oncology, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Huazhong University of Science and Technology - Department of Oncology, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 23 (1,122,371)

Abstract:

Loading...

non-small-cell lung cancer, Immune checkpoint inhibitors, chemotherapy, efficacy, dexamethasone

3.

Serum Amyloid A Flare-Response Predicts Clinical Benefit From Anti-PD-1/PD-L1 Monotherapy In Patients With Advanced Non-Small Cell Lung Cancer

Number of pages: 29 Posted: 24 Apr 2022
affiliation not provided to SSRN, Sun Yat-sen University (SYSU) - Sun Yat-sen Memorial Hospital, affiliation not provided to SSRN, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, affiliation not provided to SSRN, affiliation not provided to SSRN, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, affiliation not provided to SSRN, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 20 (1,159,618)

Abstract:

Loading...

Immunotherapy, non-small cell lung cancer, serum amyloid A, biomarker, early kinetics